Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Nitric Oxide already FDA approved

View:

Post by HighSkies2019 on Sep 14, 2020 5:22pm

Nitric Oxide already FDA approved

As well with nitic oxide already approved .... ( yes inhaled ).... R107 can possibly be moved ahead if the pandemic worsens and our 1st phase gives promising results .... at least there is some history of NO

212

Comment

Comment by Hockydad on Sep 14, 2020 8:08pm

This post has been removed in accordance with Community Policy

Comment by JMark80 on Sep 14, 2020 8:25pm

HighSkies2019, how is KLY's bone fracture program going? LOL. I actually wish they would re-visit their old pipeline. Too bad they're out of cash, completely ruined the share count, and lost the market's confidence. But Matteo really likes Robert Farrell!

130

Comment

Claritas Pharmaceuticals Inc